Ftse Mib
34.799,27
-0,83%
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
94.740,17
0,25%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Olema Pharmaceuticals Inc (OLMA) Olema Pharmaceuticals Inc (OLMA) Notizie

Olema Pharmaceuticals Inc

OLMA
5,25
0,21 (4,17%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:22:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202522:24EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/1/202513:15EDGAR2Form 8-K - Current report
10/1/202522:01EDGAR2Form 8-K - Current report
06/1/202522:06EDGAR2Form S-3 - Registration statement under Securities Act of..
03/1/202522:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/1/202513:00GLOBEOlema Oncology to Present at 43rd Annual J.P. Morgan..
18/12/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202401:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:37EDGAR2Form 144 - Report of proposed sale of securities
12/12/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202423:19EDGAR2Form 144 - Report of proposed sale of securities
11/12/202422:52EDGAR2Form 144 - Report of proposed sale of securities
11/12/202422:33EDGAR2Form 144 - Report of proposed sale of securities
11/12/202422:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
11/12/202422:27EDGAR2Form 144 - Report of proposed sale of securities
10/12/202421:23EDGAR2Form 144 - Report of proposed sale of securities
10/12/202420:48EDGAR2Form 144 - Report of proposed sale of securities
10/12/202420:38EDGAR2Form 144 - Report of proposed sale of securities
10/12/202420:14EDGAR2Form 144 - Report of proposed sale of securities
10/12/202413:15EDGAR2Form 8-K - Current report
10/12/202413:00GLOBEOlema Oncology Presents Updated Clinical Results for..
09/12/202413:00GLOBEOlema Oncology Announces FDA Clearance of Investigational..
03/12/202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/12/202413:15EDGAR2Form 8-K - Current report
02/12/202413:00GLOBEOlema Oncology Announces New Clinical Trial Collaboration..
25/11/202423:30GLOBEOlema Oncology to Present New Data Combining Palazestrant..
25/11/202401:27PRNUSAscentage Pharma Appoints Ms. Marina S. Bozilenko and Dr...
14/11/202422:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:20EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:10EDGAR2Form 8-K - Current report
12/11/202422:01GLOBEOlema Oncology Reports Third Quarter 2024 Financial Results..
06/11/202413:01GLOBEOlema Oncology to Participate in Upcoming Investor..
04/11/202422:44GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
23/10/202413:00GLOBEOlema Oncology Presents Compelling New Preclinical Data..
09/10/202413:00GLOBEOlema Oncology Announces New Preclinical Combination Data to..
02/10/202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
27/9/202413:00EDGAR2Form 8-K - Current report
04/9/202422:49GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
21/8/202413:00GLOBEOlema Oncology to Participate in Morgan Stanley 22nd Annual..
06/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:10EDGAR2Form 8-K - Current report
06/8/202422:02GLOBEOlema Oncology Reports Second Quarter 2024 Financial Results..
05/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
31/7/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:15EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 4,90 Min: 4,60 Max: 5,05
Chiusura: 5,04

La tua Cronologia

NASDAQ
OLMA
Olema Pharmaceuticals
TSX
ISV
Information Services
BIT
BFG
BF
BIT
P228M7
NLBNPIT228M7 20991231 18...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network